Telehealth vs. in-person follow-up for opioid addiction treatment
Part of Mental health clinical trials.
This study compares follow-up care after an emergency department visit for opioid addiction: either through telehealth (video visits) or in-person appointments. The goal is to see which method helps people stay in treatment after they leave the ED.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) who came to the emergency department.
- You received or were prescribed buprenorphine (a medication for opioid addiction) during that visit.
- You do not already have a regular clinic or doctor to continue your buprenorphine treatment after leaving the ED.
- You are able to understand and agree to join the study on your own.
- You are not living in a nursing home, prison, or other institution.
- You can complete questionnaires in English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps coordinate ongoing care for people who start buprenorphine, a medication for opioid use disorder, while in the emergency department. It aims to connect you with continued treatment to support your recovery.
This study tests different ways to help people who come to the emergency department with opioid use disorder. It aims to find which support strategies work best to connect them with ongoing care and reduce harm.
This trial tests whether taking buprenorphine (a medicine for opioid use disorder) through telemedicine works as well as standard in-person care. You may be enrolled if you’re seeking treatment for opioid use disorder and can safely follow study steps.
This study tests whether a tailored telehealth program can help people with opioid use disorder get better access to treatment. It is designed for patients who are already receiving or starting treatment with buprenorphine at Prevention Point Philadelphia.
This trial tests whether a telehealth program can help people with opioid use disorder get and stay on buprenorphine treatment. It aims to make care more accessible for those in vulnerable situations.
This study tests whether treatment for opioid use disorder can be done effectively through telehealth (video calls and texts). It is designed for people who are not currently on medication for opioid addiction and want to start treatment from home.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.